fluorocyclopentenylcytosine
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2013 (NCT02030067)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fluorocyclopentenylcytosine
- rx-3117
- rx-3117
- rx-3117
- tv-1360
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03189914 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2017 | Rexahn Pharmaceuticals, Inc. |
| NCT02030067 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2013 | Rexahn Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rexahn Pharmaceuticals, Inc. | For profit | 2 | 2 | 1 | 2013 |
1 organizations
Page 1 / 1